R 1499
Alternative Names: R1499Latest Information Update: 14 Mar 2006
At a glance
- Originator Roche
- Class
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 13 Dec 2004 Phase-I clinical trials in Type-2 diabetes mellitus in Switzerland (unspecified route)
- 06 Aug 2003 Preclinical trials in Type-2 diabetes mellitus in Switzerland (unspecified route)